Search


 
Results 41 - 50 of about 77 for "FDA update".

New contraindication for aliskiren-containing medications ...

Aliskiren-containing medications are contraindicated with angiotensin- converting enzyme inhibitors and angiotensin receptor blockers in patients ...

August 9, 2013 | ACP Diabetes Monthly

... to episodes of hyperglycemia. FDA update. Hemoglobin A1c test approved for diagnosis. The FDA recently approved the ...

September 16, 2016 | ACP Diabetes Monthly

... intervention to improve HbA1c testing. FDA update. Glucagon recalled due to detaching needles. Six batches of GlucaGen HypoKit ...

June 12, 2015 | ACP Diabetes Monthly

... recent analysis has found. FDA update. SGLT2 inhibitors associated with ketoacidosis. Sodium-glucose cotransporter-2 ...

August 12, 2016 | ACP Diabetes Monthly

... GLP-1 analogues. FDA update. New daily injection approved for adults with type 2 diabetes. Lixisenatide (Adlyxin), a once ...

March 14, 2014 | ACP Diabetes Monthly

... triglycerides, and quality of life. FDA update. New drug approved, meters recalled. Dapaglifozin (Farxiga), a new medication ...

August 14, 2015 | ACP Diabetes Monthly

... diabetes in a recent clinical guideline. FDA update. New weight loss device approved. A new balloon device (the ReShape ...

November 9, 2012 | ACP Diabetes Monthly

... managing adult patients with diabetes. FDA update. New drugs approved for diabetes. The first generic version of pioglitazone ...

March 13, 2015 | ACP Diabetes Monthly

... goals, according to a study. FDA update. New labels warn against sharing multi-dose insulin pens. In an effort to reduce ...

June 9, 2017 | ACP Diabetes Monthly

... gastrectomy. FDA update. Canagliflozin will receive new boxed warning about amputation risks. Canagliflozin (Invokana ...

Result Page: < Previous  1 2 3 4 5 6 7 8  Next >